Abstract
Quality assessment of genetic counseling practice for improving healthcare is a challenge for genetic services worldwide; however, there is scarce literature regarding quality issues in genetic counseling in the context of presymptomatic testing for late-onset neurological diseases (Paneque et al. 2012) The aims of this qualitative study were to: (1) explore the views of professionals’ who provide genetic counseling services for presymptomatic testing for late-onset neurological diseases regarding relevant quality indicators for counseling practice; and (2) examine current assessment of such counseling practice for Portuguese genetic services. Quality indicators are a means of measuring either the process or outcomes of patient services, with the aim of evaluating and improving quality of care (Mainz 2003). In this study, we defined quality indicators as measurable outcomes of the counseling process that may reflect good professional practice and desirable end-term effects. We undertook interviews with 18 genetic health professionals (85 % of all genetic counseling professionals involved) from the major genetic services in Portugal. Results indicate that professionals valued some core components of genetic counseling, including providing information and decision-making support, informing the consultand about the genetic counseling protocol, as well as exploring motivations, expectations for test results, consequent anticipated life changes, psychosocial adjustment, and personal and familial experience with the disease. Professionals were not, however, able to clearly elucidate quality indicators for effective practice and some reported they had not reflected on that topic before. Professionals also reported specific challenges in their practice, such as ambiguity of the health/illness status and affirming consultands’ autonomy. Results of the study have revealed a lack of knowledge about quality indicators and tools to assess counseling practice. A credible set of quality indicators for presymptomatic testing is required as a foundation for the development of specific tools.
Similar content being viewed by others
References
Almqvist, E. W., Brinkman, R. R., Wiggins, S., & Hayden, M. R. (2003). Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington’s disease. Clinical Genetics, 64(4), 300–309.
Bernhardt, C., Schwan, A. M., Kraus, P., Epplen, J. T., & Kunstmann, E. (2009). Decreasing uptake of predictive testing for Huntington’s disease in a German centre: 12 years’ experience (1993–2004). European Journal of Human Genetics, 17(3), 295–300.
Clark, M. (2005). Health care professionals’ versus patients’ perspectives on diabetes. Journal of Diabetes Nursing, 9(3), 87–91.
Cruz, T., Reynaldo, R., Cedeño, H., Laffita, J. M., González, Y., Aguilera, R., et al. (2011). Ethical dilemmas in genetic testing: examples from Cuban program for predictive diagnosis of hereditary ataxias. Journal of Genetic Counseling, 20(3), 241–248.
Cruz, T., Velázquez, L., González, Y., Aguilera, R., Velázquez, M., Vázquez, Y., et al. (2013). The Cuban program for predictive testing of SCA2: 11 years and 768 individuals to learn from. Clinical Genetics, 83(6), 518–524.
Davey, A., Rosntant, K., Harrop, K., Goldblatt, J., & O’Leary, P. (2005). Evaluating genetic counseling: client expectations, psychological adjustment and satisfaction with service. Journal of Genetic Counseling, 14(3), 197–206.
Decruyenaere, M., Evers-Kiebooms, G., Cloostermans, T., Boogaerts, A., Demyttenaere, K., Dom, R., et al. (2003). Psychological distress in the 5-year period after predictive testing for Huntington’s disease. European Journal of Human Genetics, 11(1), 30–38.
Dufrasne, S., Roy, M., Galvez, M., & Rosenblatt, D. (2011). Experience over fifteen years with a protocol for predictive testing for Huntington disease. Molecular Genetics and Metabolism, 102(4), 494–504.
Duisterhof, M., Trijsburg, R. W., Niermeijer, M. F., Roos, R. A., & Tibben, A. (2001). Psychological studies in Huntington’s disease: making up the balance. Journal of Medical Genetics, 38(12), 852–856.
Edwards, A., Gray, J., Clarke, A., Dundon, J., Elwyn, G., Gaaf, C., et al. (2008). Interventions to improve risk communication in clinical genetics: a systematic review. Patient Education & Counseling, 71(1), 4–25.
Ellington, L., Roter, D., Dudley, W., Baty, B., Upchurch, R., Larson, S., et al. (2005). Communication analysis of BRCA1 genetic counseling. Journal of Genetic Counseling, 14(5), 377–386.
Evers-Kiebooms, G. (2010). Genetic counseling for late-onset disorders. In U. Kristoffersson, J. Schmidtke, & J. J. Cassiman (Eds.), Quality issues in clinical genetic services (pp. 353–360). Berlin: Springer.
Evers-Kiebooms, G., Welkenhysen, M., Claes, E., Decruyenaere, M., & Denayer, L. (2000). The psychological complexity of predictive testing for late onset neurogenetic diseases and hereditary cancers. Social Science & Medicine, 51(6), 831–841.
Futter, M. J., Heckmann, J. M., & Greenberg, L. J. (2009). Predictive testing for Huntington disease in a developing country. Clinical Genetics, 75(1), 92–97.
Garland, A. F., Kruse, M., & Aarons, G. A. (2003). Clinicians and outcome measurement: what’s the use? Journal of Behavioral Health Services & Research, 30, 393–405.
Guimarães, L., Sequeiros, J., Skirton, H., & Paneque, M. (2013). What counts as successful in genetic counseling for presymptomatic testing in late-onset disorders? The consultands perspective. Journal of Genetic Counseling, 22(4), 437–447.
HDSA (2003). Genetic Testing for Huntington’s Disease: Its Relevance and Implications. US Huntington’s Disease Genetic Testing Group Revised. Retrieved from https://www.hdsa.org/living-withhuntingtons/publications/index.html.
Higgins, S., Veach, P. M., MacFarlane, I. M., Borders, L. D., LeRoy, B., & Callanan, N. (2013). Genetic counseling supervisor competencies: results of a Delphi study. Journal of Genetic Counseling, 22(1), 39–57.
International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea. (1994a). Guidelines for the molecular genetics predictive test in Huntington’s disease. Neurology, 44(8), 1533–1536.
International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington’s Chorea. (1994b). Guidelines for the molecular genetics predictive test in Huntington’s disease. Journal of Medical Genetics, 31(7), 555–559.
Kosonen, J., Rantanen, E., Hietala, M., Kristoffersson, U., Nippert, I., Schmidtke, J., & Kääriäinen, H. (2008). Have patient’s opinion been asked? A review of 102 studies from the years 1997–2007 on patient perspective of genetic counseling services in genetic testing situations. EuroGentest Report.
MacLeod, R., Tibben, A., Frontali, M., Evers-Kiebooms, G., Jones, A., Martinez-Descales, A., Roos, R. A., & Editorial Committee and Working Group ‘Genetic Testing Counseling’ of the European Huntington’s Disease Network. (2013). Recommendations for the predictive genetic test in Huntington’s disease. Clinical Genetics, 83(3), 221–231.
Mainz, J. (2003). Defining and classifying clinical indicators for quality improvement. International Journal for Quality in Health Care, 15(6), 523–530.
McAllister, M. (2001). Grounded theory in genetic counseling research. Journal of Genetic Counseling, 10(3), 233–250.
McAllister, M., Payne, K., Nicholls, S., MacLeod, R., Donnai, D., & Davies, L. M. (2007). Improving service evaluation in clinical genetics: identifying effects of genetic diseases on individuals and families. Journal of Genetic Counseling, 16(1), 71–83.
McAllister, M., Dunn, G., & Todd, C. (2010). Empowerment: qualitative underpinning of a new clinical genetics-specific patient-reported outcome. European Journal of Human Genetics, 19(2), 125–130.
McCarthy Veach, P., Bartels, D. M., & LeRoy, B. S. (2007). Coming full circle: a reciprocal-engagement model of genetic counseling practice. Journal of Genetic Counseling, 16(6), 713–728.
Meiser, B., Irle, J., Lobb, E., & Barlow-Stewart, K. (2008). Assessment of the content and process of genetic counseling: a critical review of empirical studies. Journal of Genetic Counseling, 17(5), 434–451.
Mendes, Á., Sousa, L., & Paneque, M. (2013). From constraints to opportunities? Provision of psychosocial support in Portuguese oncogenetic counseling services. Journal of Genetic Counseling, 22(6), 771–783.
Paneque, M., Sequeiros, J., & Skirton, H. (2012). Quality assessment of genetic counseling process in the context of presymptomatic testing for late-onset disorders: a thematic analysis of three review articles. Genetic Testing and Molecular Biomarkers, 16(1), 36–45.
Payne, K., Nicholls, S., McAllister, M., MacLeod, R., Ellis, I., Donnai, D., et al. (2007). Outcome measures for clinical genetics services: a comparison of genetics healthcare professionals and patients’ views. Health Policy, 84(1), 112–22.
Payne, K., Nicholls, S., McAllister, M., MacLeod, R., Donnai, D., & Davies, L. (2008). Outcome measurement in clinical genetics services: a systematic review of validated measures. Value in Health, 11(3), 497–508.
Resta, R. G. (2006). Defining and redefining the scope and goals of genetic counseling. American Journal of Medical Genetics, 142C, 269–275.
Rodrigues, C. S., de Oliveira, V. Z., Camargo, G., Osório, C. M., de Castilhos, R. M., Saraiva-Pereira, M. L., et al. (2012). Presymptomatic testing for neurogenetic diseases in Brazil: assessing who seeks and who follows through with testing. Journal of Genetic Counseling, 21(1), 101–112.
Rolim, L., Leite, A., Ledo, S., Paneque, M., Sequeiros, J., & Fleming, M. (2006). Psychological aspects of presymptomatic testing for Machado-Joseph disease and familial amyloid polyneuropathy type I. Clinical Genetics, 69(4), 297–305.
Royal College of General Practitioners (2013) Audit Guidance. Availbale at: http://www.rcgp.org.uk/clinical-and-research/clinical-resources/clinical-audit/audit-guidance.aspx, accessed 27 January 2014.
Silva, S. A., Costa, P. L., Costa, R., Tavares, S. M., Leite, E. S., & Passos, A. M. (2013). Meanings of quality of care: perspectives of Portuguese health professionals and patients. British Journal of Health Psychology, 18, 858–873. doi:10.1111/bjhp.12031.
Sivell, S., Elwyn, G., Gaff, C., Clarke, A. J., Iredale, R., Shaw, C., Dundon, J., Thornton, H., & Edwards, A. (2008). How risk is perceived, constructed and interpreted by clients in clinical genetics, and effects on decision making: systematic review. Journal of Genetic Counseling, 17(1), 30–63.
Skirton, H., Goldsmith, L., Jackson, L., & Tibben, A. (2013). Quality in genetic counseling for presymptomatic testing – clinical guidelines for practice across the range of genetic conditions. European Journal of Human Genetics, 21(3), 256–260.
Strauss, A., & Corbin, J. (1998). Basics of qualitative research: Techniques and procedures for developing grounded theory (2nd ed.). Thousand Oaks: Sage.
Tibben, A. (2007). Predictive testing for Huntington’s disease. Brain Research Bulletin, 72(2–3), 165–171.
Timman, R., Roos, R., Maat-Kievit, A., & Tibben, A. (2004). Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7–10 years after the test. Health Psychology, 23(2), 189–197.
Wang, C., Gonzalez, R., & Merajver, S. D. (2004). Assessment of genetic testing and related counseling services: current research and future directions. Social Science & Medicine, 58, 1427–1442.
Williams, M. S. (2009). Quality in clinical genetics. American Journal of Medical Genetics, 151C, 175–178.
Zellerino, B. C., Milligan, S. A., Gray, J. R., Williams, M. S., & Brooks, R. (2009). Identification and prioritization of quality indicators in clinical genetics: an international survey. American Journal of Medical Genetics, 151C, 179–190.
Acknowledgments
We are grateful to all professionals for their time and precious contribute to this study. We also want to thank the coordinators of the genetic centers that participated in this study – Centro de Genética Preventiva e Preditiva - Instituto de Biologia Molecular e Celular, Centro Hospitalar Universitário de Coimbra -Hospital Pediátrico, Hospital de Santa Maria, and Hospital Dona Estefânia. MP (SFRH/BPD/66484/2009) and AM (SFRH/BPD/88647/2012) were the recipients of postdoctoral fellowships from FCT (the Portuguese Foundation for Science and Technology).
Conflict of interest
All authors declare they have no conflicts of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible ethics committee on human experimentation (University of Porto) and with the Helsinki Declaration of 1975, as revised in 2008. Informed consent was obtained from all participants included in the study.
Animal Studies
No animal studies were carried out by the authors for this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Paneque, M., Mendes, Á., Guimarães, L. et al. Genetics Health Professionals’ Views on Quality of Genetic Counseling Service Provision for Presymptomatic Testing in Late-Onset Neurological Diseases in Portugal: Core Components, Specific Challenges and the Need for Assessment Tools. J Genet Counsel 24, 616–625 (2015). https://doi.org/10.1007/s10897-014-9784-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-014-9784-6